Heinz-Josef Klümpen (H J Klümpen)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Locally Advanced

Liver Metastases

Sentinel Lymph Node

Radiofrequency Ablation

Top Venues

European journal of nuclear medicine and molecular imaging

Acta oncologica (Stockholm, Sweden)

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Pim Hendriks, Daphne D D Rietbergen, Arian R van Erkel, Minneke J Coenraad, Mark J Arntz, Roel J Bennink, Andries E Braat, Stijn Crobach, Otto M van Delden, Petra Dibbets-Schneider, Tom van der Hulle, Heinz-Josef Klümpen, Rutger W van der Meer, Johannes Frank Wilhelmus Nijsen, Catharina S P van Rijswijk, Joey Roosen, Bastian N Ruijter, Frits Smit, Mette K Stam, R Bart Takkenberg, Maarten E Tushuizen, Floris H P van Velden, Lioe-Fee De Geus-Oei, Mark C Burgmans, null null
Adjuvant holmium-166 radioembolization after radiofrequency ablation in early-stage hepatocellular carcinoma patients: a dose-finding study (HORA EST HCC trial). European journal of nuclear medicine and molecular imaging 51 (7) (2024)
Simon Gray, Angela Lamarca, Julien Edeline, Heinz-Josef Klümpen, Richard A Hubner, Mairéad Geraldine McNamara, Juan W Valle
Targeted Therapies for Perihilar Cholangiocarcinoma. Cancers 14 (7) (2022)
Wouter T Zandee, Elettra Merola, Karolina Poczkaj, Louis de Mestier, Heinz-Josef Klümpen, Karen Geboes, Wouter W de Herder, Alia Munir
Evaluation of multidisciplinary team decisions in neuroendocrine neoplasms: Impact of expert centres. European journal of cancer care 31 (6) (2022)
Daphne L T Olischläger, Li Xiang Y den Boer, Eline de Heus, Linda Brom, Desiree J S Dona, Heinz-Josef Klümpen, Christina Malmose Stapelfeldt, Saskia F A Duijts
Rare cancer and return to work: experiences and needs of patients and (health care) professionals. Disability and rehabilitation (2022)
Lynn E Nooijen, Jesus M Banales, Marieke T de Boer, Chiara Braconi, Trine Folseraas, Alejandro Forner, Waclaw Holowko, Frederik J H Hoogwater, Heinz-Josef Klümpen, Bas Groot Koerkamp, Angela Lamarca, Adelaida La Casta, Flora López-López, Laura Izquierdo-Sanchez, Alexander Scheiter, Kirsten Utpatel, Rutger-Jan Swijnenburg, Geert Kazemier, Joris I Erdmann, null null
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry. Cancers 14 (10) (2022)
Ali Belkouz, Stijn Van Roessel, Marin Strijker, Jacob L van Dam, Lois Daamen, Lydia G van der Geest, Alberto Balduzzi, Andrea Benedetti Cacciaguerra, Susan van Dieren, Quintus Molenaar, Bas Groot Koerkamp, Joanne Verheij, Elizabeth Van Eycken, Giuseppe Malleo, Mohammed Abu Hilal, Martijn G H van Oijen, Ivan Borbath, Chris Verslype, Cornelis J A Punt, Marc G Besselink, Heinz-Josef Klümpen, null null
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma. British journal of cancer 126 (9) (2022)
Tim A Labeur, Quincy Hofsink, R Bart Takkenberg, Otto M van Delden, Ron A A Mathôt, Regina Schinner, Peter Malfertheiner, Holger Amthauer, Kerstin Schütte, Bristi Basu, Christiane Kuhl, Julia Mayerle, Jens Ricke, Heinz-Josef Klümpen
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial. Acta oncologica (Stockholm, Sweden) 59 (9) (2020)
Marin Strijker, Ali Belkouz, Lydia G van der Geest, Thomas M van Gulik, Jeanin E van Hooft, Vincent E de Meijer, Nadia Haj Mohammad, Philip R de Reuver, Joanne Verheij, Judith de Vos-Geelen, Johanna W Wilmink, Bas Groot Koerkamp, Heinz-Josef Klümpen, Marc G Besselink, null null
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta oncologica (Stockholm, Sweden) 58 (7) (2019)
Tim A Labeur, Sarah Berhane, Julien Edeline, Jean-Frederic Blanc, Dominic Bettinger, Tim Meyer, Jeroen L A Van Vugt, David W G Ten Cate, Robert A De Man, Ferry A L M Eskens, Alessandro Cucchetti, Laura Jayne Bonnett, Otto M van Delden, Heinz-Josef Klümpen, R Bart Takkenberg, Philip J Johnson
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib. Liver international : official journal of the International Association for the Study of the Liver 40 (1) (2019)
Tim A Labeur, David W G Ten Cate, R Bart Takkenberg, Hicham Azahaf, Martijn G H van Oijen, Otto M van Delden, Robert A de Man, Jeroen L A van Vugt, Jan Nicolaas Maria IJzermans, Ferry A L M Eskens, Heinz-Josef Klümpen
Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma. Acta oncologica (Stockholm, Sweden) 57 (11) (2018)
R Achterbergh, L A Lammers, L Kuijsten, Heinz-Josef Klümpen, R A A Mathôt, J A Romijn
Effects of nutritional status on acetaminophen measurement and exposure. Clinical toxicology (Philadelphia, Pa.) 57 (1) (2018)